209 related articles for article (PubMed ID: 19399500)
1. Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection.
Hewamana S; Pepper C; Karunanithi K; Jenkins C; Rowntree C
Ann Hematol; 2009 Nov; 88(11):1155-6. PubMed ID: 19399500
[No Abstract] [Full Text] [Related]
2. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
Kjaersgaard M; Hasle H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):717-20. PubMed ID: 16933265
[TBL] [Abstract][Full Text] [Related]
3. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
[TBL] [Abstract][Full Text] [Related]
4. Optimal response to 100 microg/kg anti-Rh(D) in two patients who had suboptimal responses to 75 microg/kg anti-Rh(D).
Varma M; Beautyman EJ; Grossbard ML
Am J Hematol; 2009 Feb; 84(2):124. PubMed ID: 19051329
[No Abstract] [Full Text] [Related]
5. Autoimmune thrombocytopenic purpura due to human immunodeficiency virus infection.
Anish Kumar RP; Thomas M; Vijayalekshmy N
J Assoc Physicians India; 1995 Oct; 43(10):702-3. PubMed ID: 8773007
[No Abstract] [Full Text] [Related]
6. Poor response to prednisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type I infection.
Matsushita K; Arima N; Ohtsubo H; Fujiwara H; Arimura K; Kukita T; Ozaki A; Hidaka S; Matsumoto T; Tei C
Am J Hematol; 2002 Sep; 71(1):20-3. PubMed ID: 12221669
[TBL] [Abstract][Full Text] [Related]
7. High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura.
Saito N; Takemori N; Hirai K; Onodera R; Watanabe S; Kohgo Y
Am J Hematol; 1996 Feb; 51(2):173-4. PubMed ID: 8579066
[No Abstract] [Full Text] [Related]
8. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
[TBL] [Abstract][Full Text] [Related]
9. [Chronic idiopathic thrombocytopenic purpura].
Treppendahl MB; Nielsen OJ
Ugeskr Laeger; 2004 Sep; 166(39):3389-93. PubMed ID: 15515391
[No Abstract] [Full Text] [Related]
10. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.
Kjaersgaard M; Edslev PW; Hasle H
Pediatr Blood Cancer; 2009 Dec; 53(7):1315-7. PubMed ID: 19722275
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of large-platelet counts in patients with immune thrombocytopenic purpura.
Michel M; Kreidel F; Chapman ES; Zelmanovic D; Bussel JB
Haematologica; 2005 Dec; 90(12):1715-6. PubMed ID: 16330456
[TBL] [Abstract][Full Text] [Related]
12. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
George JN; Raskob GE; Vesely SK; Moore D; Lyons RM; Cobos E; Towell BL; Klug P; Guthrie TH
Am J Hematol; 2003 Nov; 74(3):161-9. PubMed ID: 14587042
[TBL] [Abstract][Full Text] [Related]
13. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.
Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF
Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950
[No Abstract] [Full Text] [Related]
14. Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia.
Fresneau B; Petit A; Courcoux MF; Tabone MD; Auvrignon A; Landman-Parker J; Leverger G
Am J Hematol; 2011 Sep; 86(9):785-7. PubMed ID: 21800354
[No Abstract] [Full Text] [Related]
15. Immune thrombocytopenic purpura: why treat?
Nugent DJ
J Pediatr; 1999 Jan; 134(1):3-4. PubMed ID: 9880438
[No Abstract] [Full Text] [Related]
16. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma.
Rosoff PM; Tuttle-Newhall E; Treem WR
Med Pediatr Oncol; 2003 Jun; 40(6):402-4. PubMed ID: 12692815
[No Abstract] [Full Text] [Related]
18. [Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. A novel therapy?].
Fujimura K
Rinsho Ketsueki; 2006 Aug; 47(8):724-33. PubMed ID: 16986711
[No Abstract] [Full Text] [Related]
19. Refractory autoimmune thrombocytopenic purpura treatment with Rituximab.
Patel K; Berman J; Ferber A; Caro J
Am J Hematol; 2001 May; 67(1):59-60. PubMed ID: 11279663
[No Abstract] [Full Text] [Related]
20. Idiopathic thrombocytopenic purpura managed by intravenous anti-D.
Aggarwal P; Mittal S; Malhotra N; Bahadur A
J Obstet Gynaecol; 2012 Feb; 32(2):195-8. PubMed ID: 22296443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
